Blue Wavelength Light-blocking Glasses in ADHD-Insomnia

• Register: ClinicalTrials.gov
• Last refreshed on: 8 January 2018
• Main ID: NCT01557595
• Date of registration: 16/02/2012
• Prospective Registration: No
• Primary sponsor: University of Alabama at Birmingham
• Public title: Blue Wavelength Light-blocking Glasses in ADHD-Insomnia ADHD
• Scientific title: Evening Use of Polarized Glasses Designed to Filter Out Blue Light in Attention Deficit Hyperactivity Disorder - Delayed Circadian Rhythm Disorder Patients
• Date of first enrolment: September 2011
• Target sample size: 22
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT01557595
• Study type: Interventional
• Study design: Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
• Phase: N/A

Countries of recruitment

United States

Contacts

• Name: Rachel Fargason, MD
• Affiliation: University of Alabama at Birmingham

Key inclusion & exclusion criteria

Inclusion Criteria:

- 19 years of age and older

- Diagnosis of ADHD and DCRD

- Willingness to sign consent and participate in the study

Exclusion Criteria:

- No sleep medication for previous two weeks before screen visit (Can enroll if willing
to undergo washout period)



Age minimum: 19 Years
Age maximum: N/A
Gender: All

Health Condition(s) or Problem(s) studied

Attention Deficit Hyperactivity Disorder

Delayed Sleep Phase Type Circadian Rhythm Sleep Disorder

Intervention(s)

Device: Polarized glasses designed to filter out blue light

Primary Outcome(s)

Pittsburgh Sleep Quality Index (PSQI) at 2 Weeks After Baseline [Time Frame: 2 weeks post baseline]

Secondary ID(s)

X110825016

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Results

• Results available: Yes
• Date Posted: 12/09/2014
• URL: https://clinicaltrials.gov/ct2/show/results/NCT01557595